Bank of New Hampshire Cuts Stake in The Clorox Company (NYSE:CLX)

Bank of New Hampshire cut its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 23.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,590 shares of the company’s stock after selling 500 shares during the period. Bank of New Hampshire’s holdings in Clorox were worth $243,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Northwest Financial Advisors bought a new position in shares of Clorox in the fourth quarter worth approximately $29,000. Core Wealth Advisors Inc. bought a new position in shares of Clorox in the fourth quarter worth approximately $29,000. Fortitude Family Office LLC bought a new position in shares of Clorox in the fourth quarter worth approximately $29,000. First United Bank & Trust purchased a new stake in Clorox in the fourth quarter worth approximately $31,000. Finally, Tyler Stone Wealth Management boosted its stake in Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CLX. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price for the company in a research note on Tuesday, March 26th. UBS Group dropped their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Evercore ISI dropped their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. JPMorgan Chase & Co. dropped their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, DA Davidson reissued a “neutral” rating and set a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $146.43.

View Our Latest Stock Report on CLX

Clorox Trading Up 0.7 %

Clorox stock opened at $136.64 on Friday. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The Clorox Company has a one year low of $114.68 and a one year high of $169.14. The stock has a market capitalization of $16.97 billion, a PE ratio of 70.80, a price-to-earnings-growth ratio of 2.18 and a beta of 0.39. The business’s fifty day moving average is $137.62 and its 200 day moving average is $144.00.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the firm posted $1.51 earnings per share. Clorox’s revenue was down 5.3% compared to the same quarter last year. On average, sell-side analysts predict that The Clorox Company will post 5.91 EPS for the current year.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.